Logo | Name | Σ | ||
---|---|---|---|---|
bioMérieux Pioneering Diagnostics Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. … Sectors: Biotechnology | 416 | 323 | 63 | |
Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: Biotechnology French Cluster Public business cluster | 447 | 253 | 261 | |
IP Group plc Visionary ventures IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP … | 251 | 86 | 165 | |
Regeneron At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An … Sectors: Biotechnology Pharmaceutical | 359 | 274 | 22 | |
Oxford University Innovation Building a world-leading innovation ecosystem with Oxford University at its heart. Oxford University Innovation Limited is wholly owned by the University of Oxford. The company mission is to be the leading international technology transfer organisation, to transfer technology and expertise from the University of Oxford, to deliver value to all our clients, and to maximise social and economic benefits in a commercial manner. Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Our role is to help University staff and students bring the benefits of their research and expertise to … Sectors: Research | 186 | 76 | 79 | |
European Bioinformatics Institute | EMBL-EBI Powering big data for the life sciences Working at EMBL-EBI gives you the opportunity to focus your energy and skills on something that really matters: using technology to contribute to discoveries that benefit humankind. We empower researchers everywhere to realise the potential of ‘big data’ in biology, and build sophisticated tools for exploring life at the atomic level. Databases, Bioinformatics training, Industry, EMBL International PhD Programme, Computational biology, Software development, User experience design, Web development, Cloud technology, Data analysis, Bioinformatics, Web production, Data infrastructure, Computational research, Software, Life sciences, Open data, Open access, COVID-19 data, and Data science Sectors: Research | 167 | 116 | 48 | |
Eurofins Scientifique With ca. 62,000 staff across 62 countries, Eurofins provides testing, inspection, and certification services. Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins is a global leader in food, environmental, pharmaceutical and cosmetic product testing and in agroscience CRO services. … Tags: CAC40 Sectors: Biotechnology | 255 | 184 | 40 | |
JLR See us reimagine the future of modern luxury through our Range Rover, Defender, Discovery and Jaguar brands. Every vehicle. Every innovation. Every bit of momentum in over 170 markets worldwide. None of it would be possible without the expertise, drive and continued ambition of our people. We’re proud of our heritage, but it’s our vision for the future that excites us most. Right across our business, everybody plays a crucial role in the ever-evolving JLR journey. And with exciting new products, cutting-edge facilities and continued growth into new markets, there has never been a more exciting time to join us. … Sectors: Automobile | 2230 | 1439 | 231 |